All News

    First Patient with Colon Cancer Dosed in a Phase 2 Study of TCMCB07

    April 18th 2025, 3:00pm

    Article

    The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal cancer undergoing chemotherapy.

    Radiation Delay in NSCLC May Aid Outcomes, But Raises Toxicity Risks

    April 18th 2025, 1:00pm

    Article

    Deferring upfront CNS-directed radiation in EGFR-variant and ALK-positive NSCLC may improve outcomes but raises treatment-related toxicity risks.

    Radiation Therapy Now More Targeted and Tolerable in GI Cancer

    April 17th 2025, 9:00pm

    Article

    Radiation therapy for gastrointestinal cancers is more precise and easier to tolerate due newer technologies and personalized care, according to experts.

    Dr. Grivas Highlights Three Practice-Changing Trials in Bladder Cancer

    April 17th 2025, 8:00pm

    Video

    Dr. Petros Grivas discusses the importance of tailoring treatment decisions in bladder cancer based on data from three practice-changing phase 3 trials.

    Antibody-Drug Conjugates Changed the Standard of Care in Bladder Cancer

    April 17th 2025, 7:00pm

    Article

    Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, replacing single-agent treatments.

    New Jersey Patients Receiving First-of-Its-Kind Catheter Based Pancreatic Cancer Treatment

    April 17th 2025, 6:13pm

    Article

    Experts at Hackensack Meridian Jersey Shore University Medical Center have successfully treated their first patients using the TAMP™ therapy platform.

    How I Manage When My Social Media Friends with Cancer Disappear

    April 17th 2025, 5:00pm

    Article

    I stay in the cancer social media world because it helps me cope, even when friends disappear and I’m left wondering if they’re resting, retreating or gone.

    U.S. Centers Seek Namodenoson for Pancreatic Cancer Compassionate Use

    April 17th 2025, 4:00pm

    Article

    U.S. medical centers are seeking FDA authorization for the compassionate use — or expanded access — of Namodenoson for patients with pancreatic cancer.

    Emactuzumab Gets Fast Track Designation in Tenosynovial Giant Cell Tumors

    April 17th 2025, 3:00pm

    Article

    Emactuzumab has received fast track designation from the U.S. FDA for patients with tenosynovial giant cell tumors and who would not benefit from surgery.

    Raising Awareness on Multidisciplinary Approaches in GI Cancers

    April 17th 2025, 1:00pm

    Video

    Patients with gastrointestinal cancer may benefit from multidisciplinary care and open communication with their care team, as per an expert.